CD4 and neoplasm: Systemic treatment of sildenafil, a phosphodiesterase-5 inhibitor, resulted in decreased levels of VEGF, MDSCs, and Tregs as well as increased tumor infiltration of CD4+ T cells, but not CD8+ T cells, which also increased the survival of only tumor-bearing female mice [42].